Qkine

Qkine

Private
CambridgeHealthcare & Life Scienceshttps://qkine.com

Last Round

Debt

Dec 19, 2022

Total Funding Raised

$3.15M

Company Overview

Qkine is a biotechnology company that manufactures high-purity, animal-free growth factors, cytokines, and other complex proteins for life science applications, including stem cell and organoid culture.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Pharma Supply Chain, Clean Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

growth factorsrecombinant proteinscytokinesanimal-free proteinsstem cell cultureorganoid culturecell therapylife science reagentsregenerative medicineprotein engineeringcellular agriculturecultured meatlab-grown meatxeno-free reagentsbiomanufacturingprotein suppliercell therapy grade

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qkine Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Qkine Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
DebtDec 19, 2022
VC RoundDec 15, 2022
Series AJun 8, 2020
SeedJun 3, 2019
SeedApr 23, 2018

Qkine Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 23, 2026

    Launched QkPlate (C), pre-prepared dried vitronectin-coated plates.

  • Mar 23, 2026

    Developing QkPlate (C) human vitronectin coated plates.

Qkine Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Qkine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Qkine's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range36
Year Founded2016
Last FundingDec 19, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.